Compounding US FDA’s Problems: The High Stakes In GLP-1 Shortage Actions

 
• By Michael McCaughan
  
The FDA is facing a court challenge of its decision to end the shortage of brand GLP-1s. (Shutterstock)

More from Manufacturing

More from Compliance